Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel agents for respiratory disorders claimed in recent patents

Aug. 22, 2005

Otsuka to launch Meptin Clickhaler in Japan

Aug. 18, 2005

Recent patents reveal novel agents for respiratory diseases

Aug. 17, 2005

Phase II comparative study of R-112 for allergic rhinitis opens enrollment

Aug. 16, 2005

Inflazyme receives FDA feedback on phase III studies for IPL-512602

Aug. 10, 2005

BioMarin submits Orapred ODT NDA

Aug. 4, 2005

Therapeutic agents for respiratory and inflammatory disorders in early development

Aug. 3, 2005

MRX-3 improves asthma symptoms in animal studies

Aug. 3, 2005

MAP Pharmaceuticals expands development agreement with Elan

Aug. 2, 2005

Positive opinion handed down for Xolair in Europe

Aug. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...